Trial intelligence / Profile preview

Ulipristal acetate histopathology study in pelvic endometriosis

2013-005494-53Phase 2Unknown

Sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Start
Sep 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of ulipristal in endometriosis, sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust. Primary endpoint: Post-treatment histological appearance of ectopic endometrial deposits. Status: unknown.

02

Drugs

ulipristal
03

Conditions

endometriosis

Beyond the preview

Go deeper on 2013-005494-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005494-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call